Kasia Lemańska’s Post

On International Contraception Day, it is crucial to recall that сontraception protects against not only unwanted pregnancies but also sexually transmitted infections.  While women used to bear the burden of responsibility for contraception and the negative consequences and risks of it, today, this responsibility is shared between partners. More new contraceptive methods are being developed for both women and men, creating better opportunities for shared management of reproductive health and family planning. In the post, we will explore the revolutionizing contraception products and services.   In the Miranna app, you can discuss with your intimacy coach any aspect of your sexual well-being and intimate relationships. Join us to start a journey to your best self. P.S. In the infographic, we highlighted the following companies: YourChoice Therapeutics, Daye, Nurx from Thirty Madison, Remi Health, Zults™, Hervana Bio Ltd., Dama Health

Check out this blog from partners at Population Council, Reproductive Health Supplies Coalition, and Population Services International that highlights how vital end-user feedback is in the development of responsive MPTs that prevent pregnancy, HIV and other STIs: https://lnkd.in/eshRdh9v CAMI Health, Bethany Young Holt, PhD, MPH, Public Health Institute, Male Contraceptive Initiative

FHI 360 is leading a Phase I clinical trial for a biodegradable contraceptive implant—the first for this type of implant in over 20 years. Called Casea S, the long-acting method wouldn't require a visit to a health care provider for removal and has the potential to address some of the barriers people may face when seeking care. “Improving contraceptive access requires diversifying the variety of available methods. We believe that Casea S can offer a new and exciting contraceptive option and fill a gap in the contraceptive method mix,” says Kavita Nanda, MD, MHS, principal investigator of the Casea S study. #Contraception #Contraceptive #FamilyPlanning #FP #SexualAndReproductiveHealthandRights #SRHR  https://lnkd.in/gtFFzcFQ

Article in @dazed about women turning their backs on hormonal contraceptives - combined pill, progestin-only or mini pill and the injection are 30% down now compared to pre pandemic. (Though I wonder what difference allowing pharmacies to prescribe is now making?) When I’m out and about talking about my book Everything You Need to Know About the Pill, which looks into this, it’s clear women are now sharing more about side effects on social media and questioning being gaslighted about them. But there’s also better news - the newer pills like Zoely, Drovelis and Qlaira which contain better body-identical estrogen (but still the same old synthetic progestins) and also the fact that the smaller, lower-dose coils have less risk of depression. But what we really need is a great non-hormonal option and new male contraception, both of which are in the research pipeline - but we’ve still had to wait over 60 years for these improvements 🙄 https://lnkd.in/eJ5d6cR6

Review your preventive care coverage for 2025. The IRS issues new guidance for diabetes, contraception and breast cancer services https://ow.ly/6k4y50UcaNn #EmployeeBenefits #HealthInsurance #HealthBenefits #WTWPerspective

Review your preventive care coverage for 2025. The IRS issues new guidance for diabetes, contraception and breast cancer services https://ow.ly/fZxP50UaL8q #EmployeeBenefits #HealthInsurance #HealthBenefits #WTWPerspective

Tonight **Wednesday November 20th at 8 pm ET** Does use of progestogens increase risk of meningiomas? A webinar with medical and legal experts to address a recent study. What is the risk? What do we document in the chart? Join us for a discussion regarding the facts behind the study results, legal considerations, and guidance for addressing patients’ concerns with clarity and confidence. Register here: https://lnkd.in/eKe8i-5f #womenshealth #ObGyn #contraception

Can the coil help with endometriosis?   Many women with endometriosis have wondered about this. While the coil, also known as an intrauterine device (IUD), is primarily used for contraception, it has been found to offer some relief for women with endometriosis-related pain. The hormone-releasing IUD, such as the Mirena, releases progestin, which may help alleviate the symptoms of endometriosis, including pelvic pain and heavy menstrual bleeding. Additionally, the IUD's presence in the uterus can help inhibit the growth of endometrial tissue outside the uterus, potentially reducing the progression of the condition. However, it's important to note that the effectiveness of the IUD in managing endometriosis symptoms can vary from person to person. It's crucial for women with endometriosis to discuss their options with a healthcare professional such as us, to determine the best course of treatment for their individual needs. You can reach us at: https://lnkd.in/evCanT2j #enometriosisawareness

Yesterday, nearly 40 attendees from across the sexual and reproductive health and commissioning landscape joined Bayer in a virtual workshop exploring how developing sustainable commissioning approaches for long-acting reversible contraception (LARC) within the Integrated Care Systems (ICS) can realise a significant return on investment for women, the system and society. While women’s health is currently seeing an unprecedented policy focus, in reality many women still face a stark postcode lottery in access to different types of LARC methods – a core women’s health service – from their general practice. This means that systems are missing out on a significant return on investment: every £1 invested in the provision of LARC in primary care saves £48 in healthcare and non-healthcare costs over 10 years, while LARC can help to deliver national priorities for the NHS within and beyond the remit of the Women’s Health Strategy. Moderated by Ursula Montgomery, Bayer UK’s Head of Healthcare Policy and Partnership, supported by the FSRH – Faculty of Sexual and Reproductive Healthcare, the Bayer-led workshop aimed to support ICSs to deliver on national ambitions for Women’s Health Hubs to increase women’s access to reproductive health services, by highlighting how action to redesign LARC pathways can support achievement of ICS statutory duties to improve population health outcomes and tackle health inequalities. We would like to thank all workshop participants who represented key stakeholders across different NHS regions including the South East, the South West, London, The North West and the Midlands. As outlined in our recent consensus statement on fair and sustainable LARC provision (https://lnkd.in/erVmtmNE) continued national direction will be pivotal for creating change in this space, and helping ICSs overcome funding barriers to a more joined-up approach to LARC prescribing. We look forward to further discussions and collaborations. #FairFeesForFitting #WomensHealth #WomensHealthMatters #ReproductiveHealth #Contraception #BayerUKI

🚨 The CDC broadened pain management options for IUD insertion 🚨 This simple change to CDC's guidelines could make a HUGE difference for those seeking contraception and the level of care they receive. 👩⚕️ Check out our blog for more details on this update and why it feels like such a big step towards better, more compassionate care. https://lnkd.in/gQA-UeBJ